Emetic risk classification and evaluation of the emetogenicity of antineoplastic agents—updated MASCC/ESMO consensus recommendation

Karin Jordan*, Alexandre Chan, Richard J. Gralla, Franziska Jahn, Bernardo Rapoport, Christina H. Ruhlmann, Paula Sayegh, Paul J. Hesketh

*Corresponding author for this work

Research output: Contribution to journal › Journal article › Research › peer-review

37 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Emetic risk classification and evaluation of the emetogenicity of antineoplastic agents—updated MASCC/ESMO consensus recommendation'. Together they form a unique fingerprint.

Agricultural and Biological Sciences

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science